Bacterial vaginosis (BV) is not classified as a sexually transmitted infection (STI), but the relationship between BV and sexual activity is close enough to cause real confusion. BV is considered a “sexually associated” condition, meaning sex can trigger or worsen it, but it doesn’t spread the same way gonorrhea or chlamydia does. Understanding the distinction matters because it changes how BV is treated, whether partners need treatment, and how you think about prevention.
Why BV Isn’t Considered an STI
STIs are caused by a specific pathogen passed from one person to another during sexual contact. BV doesn’t work that way. Instead of a single invading organism, BV is a shift in the entire bacterial ecosystem of the vagina. In a healthy vaginal environment, protective bacteria called lactobacilli dominate and keep the pH acidic. In BV, those beneficial bacteria get crowded out, and the total bacterial count jumps roughly 1,000-fold, with a surge in diverse species that thrive in less acidic conditions.
The dominant player in this disrupted environment is Gardnerella, which forms a dense biofilm along the vaginal walls. Alongside it, researchers have identified a wide cast of other bacterial species that show up consistently in BV cases. But none of these bacteria act like a classic STI pathogen. They don’t invade from outside in a predictable chain of transmission. They’re often already present in small numbers and simply overgrow when conditions change.
This is also why people who have never had sex can develop BV. Anything that shifts vaginal pH or disrupts the balance of bacteria, including douching, antibiotic use, or hormonal changes, can set it off. That said, new sexual partners, unprotected sex, and sex between women are all strongly linked to BV episodes, which is why the “sexually associated” label exists.
How BV Increases Your Risk for Actual STIs
Even though BV isn’t an STI itself, having it makes you significantly more vulnerable to acquiring one. A meta-analysis of published studies found that BV increases the risk of HIV acquisition by approximately 60%. That’s not a small bump in risk, and the biological reasons are well understood.
Healthy lactobacilli produce hydrogen peroxide and keep the vaginal pH below 4.5, creating an environment that’s hostile to many pathogens, including HIV. When BV takes hold, that acidity drops and several layers of defense weaken simultaneously. The higher pH activates and multiplies the immune cells that HIV specifically targets. It also improves HIV’s ability to survive in vaginal fluid. On top of that, BV reduces levels of a natural antiviral protein that normally blocks HIV from infecting cells. The same disrupted environment also increases susceptibility to herpes, chlamydia, and gonorrhea.
What BV Feels Like
The hallmark symptom is a thin, grayish-white discharge with a fishy smell, often more noticeable after sex. The discharge tends to be uniform and milky rather than clumpy or thick. Unlike yeast infections, BV rarely causes significant itching or irritation. Many people with BV have no symptoms at all, which is part of why it goes undiagnosed so frequently.
If you’re trying to tell BV apart from an STI like trichomoniasis, the overlap can be tricky. Both cause unusual discharge and odor. Trichomoniasis is more likely to cause a yellow-green, frothy discharge with irritation, burning during urination, and visible redness. BV’s discharge is typically more subtle and the discomfort milder. But self-diagnosis is unreliable for both conditions, since the symptoms blend together easily.
How BV Is Diagnosed
Clinicians typically use a bedside evaluation called the Amsel criteria. A BV diagnosis requires at least three of four findings: thin, homogeneous discharge; vaginal pH above 4.5; a fishy odor when a chemical solution is applied to a sample (called the whiff test); and the presence of “clue cells” under a microscope, which are vaginal cells visibly coated in bacteria.
A more standardized lab method uses a scoring system based on a stained sample of vaginal fluid, grading it on a 0 to 10 scale. A score of 0 to 3 indicates a normal bacterial balance, 4 to 6 is considered intermediate, and 7 to 10 confirms BV. The intermediate range is where interpretation gets murky, and repeat testing or clinical judgment often comes into play.
Treatment and the Recurrence Problem
BV is treated with antibiotics, typically taken orally or applied as a vaginal gel or cream over the course of about a week. Most people see their symptoms clear within a few days of starting treatment. Unlike STIs such as chlamydia, current guidelines do not recommend treating male sexual partners, since BV isn’t driven by a single transmitted pathogen. Whether treating partners could help prevent recurrence is still an active question in research, particularly for female sexual partners who may share vaginal bacteria more directly.
The bigger issue with BV is that it comes back. Recurrence rates reach as high as 69% within 12 months of completing standard treatment. That’s a strikingly high failure rate, and it’s one of the most frustrating aspects of the condition. The Gardnerella-dominated biofilm that forms during BV is difficult for antibiotics to fully penetrate, which likely explains why the infection rebounds so often. For people dealing with repeated episodes, longer or suppressive courses of treatment are sometimes used to try to keep BV from returning.
BV and Pregnancy
BV during pregnancy is linked to a higher chance of preterm delivery, meaning birth before 37 weeks. Preterm birth carries serious risks for the baby, including breathing problems, brain bleeding, and in severe cases, death. However, the relationship is complicated. It’s not definitively established that BV directly causes preterm labor, and routine screening of all pregnant people for BV is not currently recommended by the U.S. Preventive Services Task Force. Pregnant people who develop symptoms are still treated, since clearing the infection may reduce other risks like postpartum infections.
Reducing Your Risk
Because BV is about the vaginal ecosystem rather than a single transmitted germ, prevention focuses on protecting that ecosystem. Douching is one of the strongest modifiable risk factors. It directly disrupts the bacterial balance and raises vaginal pH, creating exactly the conditions BV thrives in. Avoiding douching is one of the clearest preventive steps you can take.
Using condoms consistently is associated with lower BV rates, likely because semen is alkaline and temporarily raises vaginal pH. Limiting new sexual partners also reduces risk, since exposure to unfamiliar bacteria can destabilize the vaginal microbiome. For people with recurrent BV, some clinicians recommend vaginal probiotics or boric acid suppositories as adjuncts to antibiotic treatment, though the evidence for these approaches varies.
The bottom line: BV lives in a gray zone. It’s not an STI by any formal definition, but sex is one of the most common triggers, and having BV makes you more vulnerable to the infections that are. Treating it promptly and addressing recurrence matters for both comfort and broader sexual health.